News
Bristol Myers Squibb's BMY.N drug to treat a type of heart disease did not significantly improve functional capacity and ...
The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...
Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in ...
Leqembi gains European approval after CHMP reversal, despite safety concerns tied to brain swelling and bleeding in Alzheimer ...
Madrigal Pharmaceuticals has hired a former Novartis executive to succeed its retiring founder as chief medical officer.
Bright Minds Biosciences has a decent balance sheet, with roughly $40.3 million in cash. Click here to find out why I rate ...
Pain-related conditions cost the U.S. economy a staggering $635 billion annually in medical expenses and lost productivity.
The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).
The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...
After years of back-and-forth with the FDA over Hetlioz's potential use as a jet lag disorder treatment, Vanda ...
The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...
days after the Food and Drug Administration’s vaccine chief was pushed out. The agency was set to give full approval to Novavax’s shot, but senior leaders at the agency are now sitting on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results